Cargando…
Immune-Mediated Inflammation May Contribute to the Pathogenesis of Cardiovascular Disease in Mucopolysaccharidosis Type I
BACKGROUND: Cardiovascular disease, a progressive manifestation of α-L-iduronidase deficiency or mucopolysaccharidosis type I, continues in patients both untreated and treated with hematopoietic stem cell transplantation or intravenous enzyme replacement. Few studies have examined the effects of α-L...
Autores principales: | Khalid, Omar, Vera, Moin U., Gordts, Philip L., Ellinwood, N. Matthew, Schwartz, Philip H., Dickson, Patricia I., Esko, Jeffrey D., Wang, Raymond Y. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4795702/ https://www.ncbi.nlm.nih.gov/pubmed/26986213 http://dx.doi.org/10.1371/journal.pone.0150850 |
Ejemplares similares
-
Newborn Screening for Mucopolysaccharidosis I: Moving Forward Learning from Experience
por: Clarke, Lorne A., et al.
Publicado: (2020) -
Arterial Pathology in Canine Mucopolysaccharidosis-I and Response to Therapy
por: Lyons, Jeremiah A., et al.
Publicado: (2011) -
Joint contractures in the absence of inflammation may indicate mucopolysaccharidosis
por: Cimaz, Rolando, et al.
Publicado: (2009) -
An exonic insertion in the NAGLU gene causing Mucopolysaccharidosis IIIB in Schipperke dogs
por: Raj, Karthik, et al.
Publicado: (2020) -
Mucopolysaccharidosis and Autophagy: Controversies on the Contribution of the Process to the Pathogenesis and Possible Therapeutic Applications
por: Pierzynowska, Karolina, et al.
Publicado: (2019)